Researcher
Michel De Vos
- Keywords:Medicine
- Disciplines:Reproductive medicine
Affiliations
- Follicle Biology (Research group)
Member
From1 Oct 2013 → Today - Centre for Reproductive Medicine - Gynaecology (Department)
Member
From1 Jan 2008 → Today - Clinical sciences (Department)
Member
From1 Apr 2022 → Today - Clinical sciences (Department)
Member
From1 Apr 2022 → 20 Oct 2022 - Surgical clinical sciences (Department)
Member
From8 Apr 2019 → 31 Mar 2022 - Surgical clinical sciences (Department)
Member
From1 Jan 2014 → 31 Mar 2022 - Surgical clinical sciences (Department)
Member
From1 Jan 2014 → 30 Sep 2015 - Department of Embryology and Genetics (Department)
Member
From1 Oct 2013 → 31 Dec 2013 - Department of Embryology and Genetics (Department)
Member
From1 Oct 2009 → 31 Dec 2013 - Gyneacology-Urology (Department)
Member
From1 Mar 2009 → 28 Feb 2010
Projects
1 - 2 of 2
- Financing IOF-program: 4R-ART: Clinical validation of optimized In Vitro Maturation and of Oocyte Quality Test for registration purposesFrom1 Jan 2015 → 31 Dec 2019Funding: IOF - Industrial Research Fund
- Investigation of epigenetic stability and safety of assisted reproduction technologiesFrom1 Jan 2010 → 31 Dec 2013Funding: FWO research project (including WEAVE projects)
Publications
41 - 50 of 108
- The Future of Cryopreservation in Assisted Reproductive Technologies(2020)
Authors: Ernesto Bosch, Michel De Vos, Peter Humaidan
- Live births after oocyte in vitro maturation with a prematuration step in women with polycystic ovary syndrome(2020)
Authors: Thi Ngoc Lan Vuong, Anh Hoang Le Tuan, Ngoc Anh Vu Ho, Toan D Pham, Flor Sanchez, Sergio Romero, Michel De Vos, Manh Tuong Ho, Robert B Gilchrist, Johan Smitz
Pages: 347-357 - A follow-up survey on the reproductive intentions and experiences of women undergoing planned oocyte cryopreservation(2020)
Authors: Ahmed Wafi, Julie Nekkebroeck, C. Blockeel, Neelke De Munck, Herman Tournaye, Michel De Vos
Pages: 207-214 - Growth and other health outcomes of 2-year-old singletons born after IVM versus controlled ovarian stimulation in mothers with polycystic ovary syndrome(2020)
Authors: Florence Belva, Mathieu Roelants, Sietske Vermaning, Sonja Desmyttere, Jean De Schepper, Maryse Bonduelle, Herman Tournaye, Frederik Hes, Michel De Vos
- Human oocyte in-vitro maturation: optimization of the clinical approach to enhance success rates(2020)
Authors: Maria Ortega Hrepich, Michel De Vos, Johan Smitz
- ICSI does not offer any benefit over conventional IVF across different ovarian response categories in non-male factor infertility(2019)
Authors: P Drakopoulos, Juan Garcia-Velasco, Ernesto Bosch, C. Blockeel, Michel De Vos, Samuel Santos-Ribeiro, Antonis Makrigiannakis, H Tournaye, Nikolaos P Polyzos
Pages: 2067-2076 - Correction to(2019)
Authors: Panagiotis Drakopoulos, Juan Garcia-Velasco, Ernesto Bosch, C. Blockeel, Michel De Vos, Samuel Santos-Ribeiro, Antonis Makrigiannakis, Herman Tournaye, N. P. Polyzos
Pages: 2077-2078 - Modified natural cycle IVF versus conventional stimulation in advanced-age Bologna poor responders(2019)
Authors: Panagiotis Drakopoulos, Alessia Romito, Joaquín Errázuriz, Samuel Santos-Ribeiro, Biljana Popovic-Todorovic, Annalisa Racca, H Tournaye, Michel De Vos, C. Blockeel
Pages: 698-703 - Obstetric and neonatal outcome of ART in patients with polycystic ovary syndrome(2019)
Authors: Ingrid Segers, Florence Belva, Ronald Buyl, S. Santos-Ribeiro, C. Blockeel, Johan Smitz, Ellen Anckaert, Herman Tournaye, Michel De Vos
Pages: 1595-1607 - Aberrant endometrial steroid receptor expression in in-vitro maturation cycles despite hormonal luteal support(2019)
Authors: Carolina Ortega-Hrepich, Panagiotis Drakopoulos, Claire Bourgain, Inge Van Vaerenbergh, Luis Guzman, H Tournaye, Johan Smitz, Michel De Vos
Pages: 210-217